title: Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Bishop
authors.forename: Edwin P
authors.initials: EP
authors.lastname: Alyea
authors.forename: Mitchell S
authors.initials: MS
authors.lastname: Cairo
authors.forename: J H Frederik
authors.initials: JH
authors.lastname: Falkenburg
authors.forename: Carl H
authors.initials: CH
authors.lastname: June
authors.forename: Nicolaus
authors.initials: N
authors.lastname: Kröger
authors.forename: Richard F
authors.initials: RF
authors.lastname: Little
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Miller
authors.forename: Steven Z
authors.initials: SZ
authors.lastname: Pavletic
authors.forename: David
authors.initials: D
authors.lastname: Porter
authors.forename: Stanley R
authors.initials: SR
authors.lastname: Riddell
authors.forename: Koen
authors.initials: K
authors.lastname: van Besien
authors.forename: Alan S
authors.initials: AS
authors.lastname: Wayne
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Weisdorf
authors.forename: Roy
authors.initials: R
authors.lastname: Wu
authors.forename: Sergio
authors.initials: S
authors.lastname: Giralt
mesh_terms: D003226:Congresses as Topic / Q000458:organization & administration*; D006126:Group Processes; D019337:Hematologic Neoplasms / Q000473:pathology / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D054547:National Cancer Institute (U.S.); D055502:Secondary Prevention; D014184:Transplantation, Homologous; D014481:United States